August 8, 2024
SOHM, Inc., a pharmaceutical and upstart biotechnology company that manufactures and markets generic drugs covering numerous treatment categories, announced today the appointment of Dr. Tetsuya Kawamura, Ph.D., MS ’04, as a Cell Engineer and Biochemist.